EnlitenAI
Tracy · Founded 2020
About EnlitenAI
EnlitenAI is an early stage startup. NeuroLiten is our flagship AI based Product offered on the Cloud as a SaaS subscription. NeuroLiten is aimed at management and treatment of Neurological conditions, with EPILEPSY as our immediate focus. This is because, Epilepsy/Seizures offers "specificity" that is required to help build appropriate functionality & features in our platform. This can then easily be modified to expand our business into adjacent market segments for Autism/ADD, behavioral & sleep disorders, Parkinson’s Disease, Alzheimer's and other Neurological conditions. NeuroLiten platform is both scalable and extendable & is being designed as a Connected platform for personalized healthcare for Neurological conditions leveraging AI/data analytics & wearables/IOT. It is mobile and web enabled, both. Our vision is to build an end-to-end platform that creates a novel healthcare delivery system by monitoring patient vital parameters using wearables and leveraging AI/Analytics on context rich data for personalized healthcare.
Company Facts
- Founded: 2020
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $605.0K
- Funding stage: Seed
- Last round: Pre-Seed (May 2023)
- Website: https://www.enlitenai.com
- Phone: +1 408-483-1742
Industries & Categories
Internet of Things, Machine Learning, Medical Device, Wearables
Social Profiles
Canonical: https://fsome.com/organization/enlitenai-62708 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.